Premier Alternatives

Gencove

New York, NY · Founded 2015 · Privately Held (backing)

Developer of a sequencing platform designed to make whole-genome sequencing fast, affordable, and actionable. Gencove is based in New York, NY and was founded in 2015. It was valued at $50 million at its later-stage round in Oct 2021, the last priced event on record. It has raised $16 million across 3 recorded rounds; the latest was a $9.8 million early-stage round in Oct 2021.

PMV mark · valuation
$50.0M
Oct 2026
Priced at
its later-stage round
Oct 2021
Total raised
$16.0M
Last round
Early Stage VC
Oct 2021

Gencove key facts

as of Oct 2026
  • Developer of a sequencing platform designed to make whole-genome sequencing fast, affordable, and actionable.
  • Gencove is valued at approximately $50.0M as of Oct 2026, set at its later-stage round, Oct 2021; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $16.0M across 3 recorded rounds; the latest was Early Stage VC ($9.8M) in Oct 2021.
  • Notable investors include SV Angel, Alexandria Venture Investments, Refactor Capital, Third Kind Venture Capital, Spero Ventures — 13 tracked in total.
  • Gencove has filed 4 Form Ds with the SEC since 2019, most recently Nov 2021 ($9.8M sold to 8 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$50.0M

Valued at $50.0M at its later-stage round, Oct 2021. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Gencove with a free account
  • ·The complete investor list: 13 names
  • ·Watch Gencove: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Gencove funding rounds

3 rounds
Oct 2021Early Stage VC$9.8MSEC filing▮
Feb 2021Seed Round$1.8MSEC filing▮
Jan 2019Seed Round$2.7MSEC filing▮
Full funding history →

Gencove valuation

Gencove was valued at $50 million at its later-stage round in Oct 2021. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Gencove raised?

Gencove has raised $16 million across 3 recorded rounds since 2019. The largest was a $9.8 million early-stage round in Oct 2021.

Gencove has filed 4 Form Ds with the SEC since 2019, most recently in Nov 2021 ($9.8 million sold to 8 investors).

Gencove investors

13 investors are on record for Gencove, including SV Angel, Alexandria Venture Investments, Refactor Capital and Third Kind Venture Capital. By type, the record holds 4 venture capital firms and 1 growth equity firm. The early-stage round in Oct 2021 drew 8 investors.

About Gencove

Developer of a sequencing platform designed to make whole-genome sequencing fast, affordable, and actionable. The company develops molecular and computational tools to enable high-throughput and low-cost genome sequencing technology for industries from agriculture to pharma, enabling researchers to have access to genomic data.

Sector
Business Products and Services (B2B)
HQ
New York, NY, United States
Founded
2015
Employees
16
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.